[Extragonadal endocrine repercussions of long-term estro-progestational treatment].
D000311:Adrenal Glands / Q000187:drug effects; D000450:Aldosterone / Q000652:urine; D000804:Angiotensin II / Q000097:blood; D001786:Blood Glucose / Q000032:analysis; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004702:Endocrine Glands / Q000187:drug effects*; D004967:Estrogens / Q000009:adverse effects*; D005260:Female; D005947:Glucose; D006801:Humans; D007328:Insulin / Q000097:blood; D010902:Pituitary Gland / Q000187:drug effects; D011372:Progestins / Q000009:adverse effects*; D012083:Renin / Q000097:blood; D013961:Thyroid Gland / Q000187:drug effects
D001786:Blood Glucose; D003276:Contraceptives, Oral; D004967:Estrogens; D007328:Insulin; D011372:Progestins; D000804:Angiotensin II; D000450:Aldosterone; D012083:Renin; D005947:Glucose
Retentissements endocriniens extragonadiques des traitements oestro-progestatifs a long terme